BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 32535383)

  • 1. Tangshen formula modulates gut Microbiota and reduces gut-derived toxins in diabetic nephropathy rats.
    Zhao T; Zhang H; Yin X; Zhao H; Ma L; Yan M; Peng L; Wang Q; Dong X; Li P
    Biomed Pharmacother; 2020 Sep; 129():110325. PubMed ID: 32535383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic Effects of Tangshen Formula on Diabetic Nephropathy in Rats.
    Zhao T; Sun S; Zhang H; Huang X; Yan M; Dong X; Wen Y; Wang H; Lan HY; Li P
    PLoS One; 2016; 11(1):e0147693. PubMed ID: 26807792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tangshen Formula alleviates inflammatory injury against aged diabetic kidney disease through modulating gut microbiota composition and related amino acid metabolism.
    Chen DQ; Zhang HJ; Zhang W; Feng K; Liu H; Zhao HL; Li P
    Exp Gerontol; 2024 Apr; 188():112393. PubMed ID: 38458480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. QiDiTangShen granules modulated the gut microbiome composition and improved bile acid profiles in a mouse model of diabetic nephropathy.
    Wei H; Wang L; An Z; Xie H; Liu W; Du Q; Guo Y; Wu X; Li S; Shi Y; Zhang X; Liu H
    Biomed Pharmacother; 2021 Jan; 133():111061. PubMed ID: 33378964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tangshen formula attenuates diabetic renal injuries by upregulating autophagy via inhibition of PLZF expression.
    Zhao H; Li X; Zhao T; Zhang H; Yan M; Dong X; Chen P; Ma L; Li P
    PLoS One; 2017; 12(2):e0171475. PubMed ID: 28182710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Tangshen Formula on urinary and plasma liver-type fatty acid binding protein levels in patients with type 2 diabetic kidney disease: post-hoc findings from a multi-center, randomized, double-blind, placebo-controlled trial investigating the efficacy and safety of Tangshen Formula in patients with type 2 diabetic kidney disease.
    Yang X; Zhang B; Lu X; Yan M; Wen Y; Zhao T; Li P
    BMC Complement Altern Med; 2016 Jul; 16():246. PubMed ID: 27460780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Huangkui capsule alleviates renal tubular epithelial-mesenchymal transition in diabetic nephropathy via inhibiting NLRP3 inflammasome activation and TLR4/NF-κB signaling.
    Han W; Ma Q; Liu Y; Wu W; Tu Y; Huang L; Long Y; Wang W; Yee H; Wan Z; Tang R; Tang H; Wan Y
    Phytomedicine; 2019 Apr; 57():203-214. PubMed ID: 30785016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic Effects of Tangshen Formula on Diabetic Nephropathy in
    Fan XM; Huang CL; Wang YM; Li N; Liang QL; Luo GA
    J Diabetes Res; 2018; 2018():8237590. PubMed ID: 29682583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulating the gut microbiota and inflammation is involved in the effect of Bupleurum polysaccharides against diabetic nephropathy in mice.
    Feng Y; Weng H; Ling L; Zeng T; Zhang Y; Chen D; Li H
    Int J Biol Macromol; 2019 Jul; 132():1001-1011. PubMed ID: 30946910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tangshen formula protects against podocyte apoptosis via enhancing the TFEB-mediated autophagy-lysosome pathway in diabetic nephropathy.
    Wang Y; Peng L; Lu X; Zhang H; Zhao H; Zhao T; Yang L; Mao H; Ma F; Liu T; Li P; Zhan Y
    J Ethnopharmacol; 2024 Apr; 324():117721. PubMed ID: 38199335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cordyceps cicadae polysaccharides ameliorated renal interstitial fibrosis in diabetic nephropathy rats by repressing inflammation and modulating gut microbiota dysbiosis.
    Yang J; Dong H; Wang Y; Jiang Y; Zhang W; Lu Y; Chen Y; Chen L
    Int J Biol Macromol; 2020 Nov; 163():442-456. PubMed ID: 32592781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Qing-Re-Xiao-Zheng Formula Modulates Gut Microbiota and Inhibits Inflammation in Mice With Diabetic Kidney Disease.
    Gao Y; Yang R; Guo L; Wang Y; Liu WJ; Ai S; Woon TH; Wang Z; Zhai Y; Wang Z; Peng L
    Front Med (Lausanne); 2021; 8():719950. PubMed ID: 34604258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emodin via colonic irrigation modulates gut microbiota and reduces uremic toxins in rats with chronic kidney disease.
    Zeng YQ; Dai Z; Lu F; Lu Z; Liu X; Chen C; Qu P; Li D; Hua Z; Qu Y; Zou C
    Oncotarget; 2016 Apr; 7(14):17468-78. PubMed ID: 27003359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of artesunate supplementation on bacterial translocation and dysbiosis of gut microbiota in rats with liver cirrhosis.
    Chen YX; Lai LN; Zhang HY; Bi YH; Meng L; Li XJ; Tian XX; Wang LM; Fan YM; Zhao ZF; Han DW; Ji C
    World J Gastroenterol; 2016 Mar; 22(10):2949-59. PubMed ID: 26973391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apple-Derived Pectin Modulates Gut Microbiota, Improves Gut Barrier Function, and Attenuates Metabolic Endotoxemia in Rats with Diet-Induced Obesity.
    Jiang T; Gao X; Wu C; Tian F; Lei Q; Bi J; Xie B; Wang HY; Chen S; Wang X
    Nutrients; 2016 Feb; 8(3):126. PubMed ID: 26938554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut microbiota dysbiosis-induced activation of the intrarenal renin-angiotensin system is involved in kidney injuries in rat diabetic nephropathy.
    Lu CC; Hu ZB; Wang R; Hong ZH; Lu J; Chen PP; Zhang JX; Li XQ; Yuan BY; Huang SJ; Ruan XZ; Liu BC; Ma KL
    Acta Pharmacol Sin; 2020 Aug; 41(8):1111-1118. PubMed ID: 32203081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tangshen formula targets the gut microbiota to treat non-alcoholic fatty liver disease in HFD mice: A 16S rRNA and non-targeted metabolomics analyses.
    Wang S; Li X; Zhang B; Li Y; Chen K; Qi H; Gao M; Rong J; Liu L; Wan Y; Dong X; Yan M; Ma L; Li P; Zhao T
    Biomed Pharmacother; 2024 Apr; 173():116405. PubMed ID: 38484559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potential role of the gut microbiota in modulating renal function in experimental diabetic nephropathy murine models established in same environment.
    Li Y; Su X; Gao Y; Lv C; Gao Z; Liu Y; Wang Y; Li S; Wang Z
    Biochim Biophys Acta Mol Basis Dis; 2020 Jun; 1866(6):165764. PubMed ID: 32169506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shenyan Kangfu tablet alleviates diabetic kidney disease through attenuating inflammation and modulating the gut microbiota.
    Chen Q; Ren D; Wu J; Yu H; Chen X; Wang J; Zhang Y; Liu M; Wang T
    J Nat Med; 2021 Jan; 75(1):84-98. PubMed ID: 32997272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut Microbiota Mediates the Protective Effects of Traditional Chinese Medicine Formula Qiong-Yu-Gao against Cisplatin-Induced Acute Kidney Injury.
    Zou YT; Zhou J; Zhu JH; Wu CY; Shen H; Zhang W; Zhou SS; Xu JD; Mao Q; Zhang YQ; Long F; Li SL
    Microbiol Spectr; 2022 Jun; 10(3):e0075922. PubMed ID: 35481834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.